Shaping the Future Industry Sponsored Research in Malaysia. College Physician 12 Nov 2017 Dr Akhmal Yusof CEO Clinical Research Malaysia
|
|
- George Cain
- 5 years ago
- Views:
Transcription
1 Shaping the Future Industry Sponsored Research in Malaysia College Physician 12 Nov 2017 Dr Akhmal Yusof CEO Clinical Research Malaysia 1
2 Outline Introduction Meeting socio-economic demand of the country CRM Strategies: Where are we heading? Closing notes
3 Oncology ISR provide at least RM17 million worth of medication since 2013 to MoH
4 Board Of Directors A non-profit company wholly owned by Ministry of Health to create a supportive environment and complete ecosystem to grow Industry Sponsored Research (ISR) YB Datuk Seri Dr. S. Subramaniam Minister of Health, Malaysia YB Senator Datuk Prof Dr. Sim Kui Hian Senior Consultant Cardiologist Y. Bhg. Dato Seri Dr. Chen Chaw Min Secretary General in the Ministry of Health, Malaysia Y. Bhg. Datuk Dr. Noor Hisham Director General of Health, Malaysia Y. Bhg. Datuk Dr. Shahnaz Murad Deputy Director General of Health (Research & Technical Support) in the Ministry of Health, Malaysia Y. Brs. Dr. Goh Pik Pin Director of the National Clinical Research Centre, Malaysia Mr Ewe Kheng Huat Executive Director of the Pharmaceutical Association of Malaysia Prof Dr Adeeba Binti Kamarulzaman Dean of the Medical Faculty at Universiti Malaya 4
5 Adhere to We will gain TRUST TRUST need to be maintain
6 Building a Trusted Organisation 1. Respect diversities whistleblowing policy 2. Integrity ABAC/FCPA 3. Professional Business Conduct No Gifts policy 4. Protecting company assets-ip protection 5. Behaving in community
7 Good Legal Review System Standard Operating Procedure in place reviewed and approved within 14 days reviewed by PUU Min of Health Transparent with presentation to PUU office quarterly Governed by Malaysia law Arbitration in Kuala Lumpur Indemnity to cover Institution and Study Team
8 Good Financial Control System Standard Operating Procedure reviewed and approved by KSU office reviewed by Integriti Transparent with statement of account Audited by external auditor
9 Scope of Services
10 CRM believes in delivering Deliver the commitment : I am Aware campaign, Clinical Trial Day, Clinical Trial List in CRM website Relia bility Spee d Quality Quick Startup time : Improve internal timeline Feasibility, Budget Negotiation, Fast recruitment within 100 days Quality Data Delivery : Protocol Deviation Workshop & GCP Refresher
11 How are we performing?
12 Where does Malaysia stand in SEA ( ) Country Number of ISRs* ( /12/2016) Thailand 741 Singapore 600 Malaysia 311 Philippines 207 Vietnam 154 Indonesia 111 Source: ClinicalTrials.gov, 20 th January2017 * Studies received from 01/01/2013 to 12/31/
13 THERAPEUTIC AREA No. of Approved Trials Classification of Trials approved by ECs in 2016 (Jan Dec 2016, n=162) No. of Trials approved by ECs in Malaysia in 2016 according to Therapeutic Area (Jan-Dec 2016, n=162) Interventional (Drug) 52 Observational/Non-Interventional Jan- Dec16 Yr BABE Studies Medical Device Phases of the Trials approved in 2016 (n=162) BE Cardiology / Vascular Diseases Oncology Endocrinology Pulmonary / Respiratory Disease Infectious Disease Paediatrics Neurology Hematology Dermatology Rheumatology Opthalmology Nephrology Hepatology Gastroenterology Vaccine Urology Psychiatry Orthopedic Nutrition Anaesthesiology Public Health / Epidemiology O&G Immunology Epidemiology Advanced Therapy Medicinal Product (ATMP) No. of Trials Approved in NO. OF TRIALS
14
15 Speed : Quick start up time Countries Regulatory Timeline Ethics Submission Singapore Approx. 30 days Approx. 30 days Parallel MALAYSIA Approx. 30 business days Approx. 50 business days Parallel South Korea Approx. 30 days Approx. 50 days Parallel Hong Kong business days days Parallel Japan Approval is by default if no objections within 30 days 4 8 weeks Sequential Taiwan Approx. 30 business days Approx business days Both Philippines 8-12 weeks 8-12 weeks Both Source: George Clinical India 15
16 Meeting socio-economic demands of the country
17 CRM s 2020 KPI Targets 1000 ISRs (new & ongoing) (GNI) RM 578 million 1000 New Hi-Skill Jobs new & ongoing ISRs GNI of RM mil 1118 skill jobs 2017 (Sep) 1055 new & ongoing ISRs GNI of RM mil 1491 skill jobs 17
18 CRM strategies : Where are we heading?
19 Early Phase trials via P1RP 1000 ISR by 2020 Optimizing Oncology ISR via 3P-O and CRM-IKN support First PI growth since 2010 ( 185 in 2016 vs 69 In 2015) New collaboration with DNDi, Univesities (Glasgow, Lancaster, Birmingham, Newcastle, Warwick, Cambridge & Melbourne) 1.4 Million hit for website, Media presence in print media, 6 International missions Fastest growing site managers with 30% increase headcounts providing resources in public & private sectors
20 CRM 5 year strategies (2017 to 2020) Clinical Research Excellence and Advancement Centre Malaysia (CREAM) To manage own dedicated centre specializing on early phase development and oncology To complete the Clinical/Scientific ecosystem and drive research that matters for Healthcare solutions Project Accelerate 5 year Blue print Sustainable Value Proposition (SVP) Project To create research training academy that is respectable in the SEA region
21 Phase 1 Realisation Project (P1RP) Updates Pillar 1 Pillar 2 Pillar 3 Pillar 4 Pillar 5 Guidelines for Phase 1 CT People Development Capability Development Preparation of Sites Risk Management Launch November 2017 NPRA officer sponsored by CRM to study at Christie Manchester Oct 2017 Scientific Review Panel lists finalized and awaiting appointment by YBMK Ampang CTU and Sarawak GH Phase I Unit ready Crisis Manual Completed NPRA = National Pharmaceutical Regulatory Agency
22 Phase 1 Guideline available in CRM website
23 ACCELERATE Pre Clinical projects with Clinical/Scientific organization Collaboration with local Universities/MoH for Bench to Bedside Projects P1RP Centralized Lab for the region DNDi Translational Head visit to CRM and Sarawak Biodiversity Corporation in April 2017 IMR & Aurigene work for Novel Anti-Cancer Compounds & Associated Biomarkers recruitment started in October 2017
24 ACCELERATE Pre Clinical projects with Clinical/Scientific organization Collaboration with local Universities/MoH for Bench to Bedside Projects P1RP Centralized Lab for the region NHAM CRM Research Track showcased basic science, translational research as well as late stage clinical research from various institutions in Malaysia including all universities in the areas of Cardiology
25 ACCELERATE Pre Clinical projects with Clinical/Scientific organization Collaboration with local Universities/MoH for Bench to Bedside Projects P1RP Centralized Lab for the region
26 ACCELERATE Pre Clinical projects with Clinical/Scientific organization Collaboration with local Universities/MoH for Bench to Bedside Projects P1RP Centralized Lab for the region Visit to Hematogenix- Planning to Open lab to cater for Asian Clinical Trials sites in Malaysia
27 Growth of Sponsors (Aug) 142 CAGR 44%
28 FULL FEASIBILITY COUNT FULL FEASIBILITY STUDY GROWTH CAGR 12% YEAR Higher Full feasibility in Aug 2017 compared to full year Average conversion rate of 12% currently vs 10% in 2016
29 Creating Awareness About Clinical Research
30 I AM AWARE ROADSHOW LOCATIONS Upcoming:
31 16 th MAY 2017 INSTITUT KANSER NEGARA (IKN), PUTRAJAYA
32 The launching of Clinical Trials Day Officiated by the Minister of Health, Datuk Seri Dr. S. Subramaniam at National Cancer Institute, PUTRAJAYA -(16 May 2017). To celebrate the Clinical Trials Day launch, 33 satellite hospitals across Malaysia, conducted the I Am Aware roadshow to further drive awareness among public.
33 What could ISR contribute?
34 The intangible value of ISR TECHNOLOGY TRANSFER DESIGN STUDY PROTOCOL STUDY METHODOLOGY DATA MANAGEMENT EXPANDING RESOURCES INCREASE TREATMENT OPTIONS FOR THE PEOPLE PROVIDE RESOURCES TO STUDY SITES PROVIDE NEW KNOWLEDGE GLOBAL RECOGNITION CONSISTENT TIMELINE RELIABILITY & QUALITY PUBLICATION
35 2016 : 1 ISR 2017 : 7 ISRs
36
37 MN companies Local companies
38 We believe CRM provides global health solutions for the people through clinical research Our deep understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the MoH provide us an incomparable advantage to deliver research and create high skilled job opportunities
39 Thank you Visit w w w. c l i n i c a l r e s e a r c h. my 39
Excellence in Trial Management
Excellence in Trial Management COMPANY OVERVIEW Privately held company Founded in 2007 Contract Research Organization HQ in Montréal, Canada Specialized in Clinical Development & Trial Management Client
More informationDengue: A disease burden in Sri Lanka A Complex Phase III Vaccine Trial
Dengue: A disease burden in Sri Lanka A Complex Phase III Vaccine Trial Country Overview Size: 65,610 sq km Population: 21,324,791 Population growth rate: 0.904% Population: Not genetically homogeneous
More informationReady for a CRO That Values Performance Over Promises? CHALLENGE. At Clinipace, it s personal.
Ready for a CRO That Values Performance Over Promises? CHALLENGE At Clinipace, it s personal. Who We Are At Clinipace, It s Personal. We Will PROVE IT. With us, you get the A team. We deliver a level of
More informationHealth Task Force Workplan
2006/SOM 3/HTF/021 Agenda Item: VI Health Task Force Workplan 2006-2007 Purpose: Information Submitted by: Chair Health Task Force Meeting Da Nang, Viet Nam 14 15 September 2006 APEC HEALTH TASK FORCE
More informationCharité Research Organisation Our Concept
Charité Research Organisation Our Concept Charité Research Organisation Charité owned operationally independent scientifically driven Experience Conducted more than 300 First Time in Human, Phase 1 and
More informationNetworking Clinical Trials Anna Shevlin, Clinical Trial Liaison Officer
Networking Clinical Trials Anna Shevlin, Clinical Trial Liaison Officer HRB CRCI International Clinical Trial Networks Networking Clinical Trials Clinical Research Infrastructure Disease Clinical Research
More informationLaunching of Clinical Practice Guidelines on the Management of Glaucoma (Second Edition)
Launching of Clinical Practice Guidelines on the Management of Glaucoma (Second Edition) (L - R) Associate Professor Dr Amir Samsudin, Organising Chairperson 7th Conjoint Ophthalmology Scientific Conference
More informationMichal Roll PhD, MBA Director, R&D Division
Michal Roll PhD, MBA Director, R&D Division Dr. Michal Roll Director, R&D Division Ofer (Heart & Brain) Emergency Underground Hospital Arison (Surgery & Oncology) Nursing School Sourasky (Medicine) Lis
More informationCELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH
CELEBRATING 169 YEARS OF TRADITION AND TRANSFORMATION IN HEALTHCARE RESEARCH Our MISSION Building on our tradition Reaching out to the community Doing our best to serve, care and heal Together, we aim
More informationDisclaimer. The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be
Ending the Myths: Best Practice in Trial Conduct in Latin America Katie Margules Global Vice President Alliance Management Covance Disclaimer The views and opinions expressed in the following PowerPoint
More informationCTA Strengths. Organisational Structure Board. CTA Board CEO. Background to Cancer Trials Australia What we do well An increasing struggle Conclusions
Models for Clinical Research: Cancer Trials Australia Professor Mark Rosenthal Chairman; Cancer Trials Australia and Director of Medical Oncology, Royal Melbourne Hospital For discussion: Background to
More informationOffice of Clinical Research Annual Report 2017 July 1, June 30, 2017
Office of Clinical Research Annual Report 2017 July 1, 2016- June 30, 2017 Table of Contents Title Page Number Mission Statement 1 Objective 1 Research Services 1 Research Highlights 2 Figure 1 Number
More informationFINPEDMED & ICEPEDMED
FINPEDMED & ICEPEDMED 13 June.2017, Helsinki www.finpedmed.fi www.finpedmed.com Pirkko Lepola Executive Secretary of FINPEDMED General Secretary of NORDICPEDMED Helsinki University Hospital, Department
More informationTowards a Sustainable Global Infrastructure for Medical Countermeasures
Towards a Sustainable Global Infrastructure for Medical Countermeasures Institute of Medicine The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from
More informationClinical Research Resources
Clinical Research Resources SOM New Faculty Orientation August 2017 Pamela G. Terry, MBA, JM Associate Executive Director, University Resources ACTSI Atlanta Clinical & Translational Science Institute
More informationState of the Network. TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008
State of the Network TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008 Research Community Education TAHOD Program Update Current recruitment of ~4,000 patients from 17 sites in 12 countries
More informationFIRST EDITION PRIMARY CARE REFERRAL GUIDELINES
FIRST EDITION PRIMARY CARE REFERRAL GUIDELINES 1 Primary Care Referral Guidelines All rights reserved. This material may be freely reproduced for educational and not for profit purposes. No reproduction
More informationEuropean Paediatric Network Legal Basis
Enpr-EMA Joint DIA/EFGCP/EMA Paediatric Forum 26 September 2011 Paolo Rossi Chairman Dept. of Pediatrics Tor Vergata University-Children s Hospital Bambino Gesù, Rome EnprEMA-PDCO Representative An agency
More informationSUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS
Health & Life Sciences SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS A CROSS-SECTOR APPROACH TO DIET-RELATED CHRONIC DISEASE A breakfast discussion as part of Oliver Wyman s participation in
More informationContribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone
COMMUNICATIONS AND AWARENESS MANAGER OVARIAN CANCER AUSTRALIA Contribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone National role Location: Melbourne CBD Position
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationReport to the. GAVI Alliance Board June 2013
Report to the GAVI Alliance Board 11-12 June 2013 Subject: Report of: Authored by: Risk Management Update Helen Evans, Deputy CEO Ciara Goldstein, Analyst, Performance Management and Adrien de Chaisemartin,
More informationWCO Strategic Initiatives for Trade Facilitation
International Seminar on Trade Facilitation in North East Asia 13 December 2016 Incheon, Republic of Korea WCO Strategic Initiatives for Trade Facilitation Ms. Alpha WONG World Customs Organization (WCO)
More information1ST MALAYSIAN MULTI-SPECIALTY-GP CONFERENCE ON IMIDs OF THE SKIN, JOINTS AND GUT 2018
Private Medical Practitioner s Association of Selangor and Kuala Lumpur Malaysian Society of Gastroenterology & Hepatology 1ST MALAYSIAN MULTI-SPECIALTY-GP CONFERENCE ON IMIDs OF THE SKIN, JOINTS AND GUT
More informationThe potential of South East Asia and India as the hub for vaccine studies
The potential of South East Asia and India as the hub for vaccine studies Angela Chen Therapeutic Strategy Lead 16 November 2017 Copyright 2017 IQVIA. All rights reserved. The potential of South East Asia
More informationASEAN and the Changing Geopolitics of Southeast Asia
ASEAN and the Changing Geopolitics of Southeast Asia Min Shu School of International Liberal Studies Waseda University 20 November 2017 IR of Southeast Asia 1 Outline of the Lecture ASEAN and its regional
More informationConsultant Services to Kansas Family Physicians
Consultant Services to Kansas Family Physicians The purpose of this study is to track the use of consultants. An e-mail survey was sent to 114 Kansas family physicians The survey was launched on 11/25/2009
More informationPOSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION
POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:
More informationRESEARCH BUSINESS DEVELOPMENT MANAGER OVARIAN CANCER AUSTRALIA
RESEARCH BUSINESS DEVELOPMENT MANAGER OVARIAN CANCER AUSTRALIA Work as part of a committed and passionate team Join a dynamic and growing not-for-profit organisation Location: Position Reports to: Direct
More informationInnovations in Halal Logistics
Innovations in Halal Logistics Presented by Datuk Che Azizuddin Che Ismail Chief Executive Officer 5th World Halal Research Summit 2012 Kuala Lumpur Convention Centre, 4 th April 2012 Table of Content
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationChampioning patients every step of the way
Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion
More informationEnhancing Patient Care: Implementing Advance Care Planning (ACP) Initiative In Singapore General Hospital (SGH)
Enhancing Patient Care: Implementing Advance Care Planning (ACP) Initiative In Singapore General Hospital (SGH) Esaias Poh Liang Jie, Programme Executive Darlene Hong Yun Quan, Programme Coordinator 21
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationHalal Training & Opportunity in Global Halal Market MSD RETIRING STAFF TRAINING PROGRAMME, AEIC CONFERENCE ROOM,2007
Halal Training & Opportunity in Global Halal Market MSD RETIRING STAFF TRAINING PROGRAMME, AEIC CONFERENCE ROOM,2007 INTRODUCTION Eat and drink of that which God has provided and act not corruptly, making
More informationPCI in Asia Pacific Region. Angioplasty Summit TCT Asia Pacific th April 2006
PCI in Asia Pacific Region Angioplasty Summit TCT Asia Pacific 2006 27 th April 2006 PCI inasia Pacific Region Pakistan Bangladesh Brunei Philipines AUSTRALIA Started 1981 Population: 20.5 million Growth
More informationUsing the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment
Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Rachael Eckles, JD/MA Director, Regulatory Policy Bristol-Myers Squibb August 10,
More informationThe next steps
Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater
More informationA/P Regional Capacity Building Approach Overview
WCO A/P Regional Workshop on Strategic Initiative for Trade Facilitation 16-18 March 2015 Jakarta, Indonesia A/P Regional Capacity Building Approach Overview Kazunari IGARASHI1 Head of the ROCB A/P Presentation
More informationON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS
ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS Introduction The ECR Asia Pacific OSA working group conducted an online survey between July and September 2011 aimed at gaining insights
More informationStrengthening Veterinary Services in Asia
Strengthening Veterinary Services in Asia 4 th Steering Committee Highly Pathogenic Emerging and Re-Emerging Diseases (HPED) Programme Session 3 Progress on the OIE component Tokyo (Japan) 16 July 2013
More informationMULTINATIONAL HEART FAILURE STUDY SHOWS HIGH PREVALENCE OF CORONARY ARTERY DISEASE, HYPERTENSION AND DIABETES IN ASIAN PATIENTS
MEDIA RELEASE 16 June 2016 MULTINATIONAL HEART FAILURE STUDY SHOWS HIGH PREVALENCE OF CORONARY ARTERY DISEASE, HYPERTENSION AND DIABETES IN ASIAN PATIENTS A multinational study involving over 5,000 heart
More informationImproving access to medicines for patients in lower-income countries
Improving access to medicines for patients in lower-income countries AHBS II Dakar November 6, 2017 Our access strategy: tailoring our approach to income segments Income segments 1 High Income Upper-middle
More informationMedpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies.
THE POWER OFx MEDPACE ADVANTAGE FOR LIPID STUDIES Experts. Experience. Execution. Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development
More informationAnother Record Year for Bayer HealthCare Pharmaceuticals in Asia Pacific
News Release Bayer (South East Asia) Pte Ltd Communications 63 Chulia Street OCBC Centre East, 14 th Floor Singapore 049514 Tel. +65 6496 1888 Co. No.: 197901344Z Another Record Year for Bayer HealthCare
More informationYuppadee JAVROONGRIT, Ph.D.
Plenary 4- Collaboration & Cooperation among Regulatory Agencies Recent Developments in Cooperation of Regulatory Authorities among ASEAN countries by Yuppadee JAVROONGRIT, Ph.D. Assistant Director, Drug
More informationThe Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016
The Prime Minister s Challenge on Dementia 2020 1 Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 Costs and impact of dementia Estimated 676,000 people in England with
More informationSPONSORSHIP INFORMATION DOCUMENT. Izzy Dempsey Nov 2018 Hong Kong. 29 Nov - 1 Dec 2017 Halifax, Canada
SPONSORSHIP INFORMATION DOCUMENT 2018 Izzy Dempsey 14-16 Nov 2018 Hong Kong 29 Nov - 1 Dec 2017 Halifax, Canada WOC SUSTAINABLE OCEAN SUMMIT The challenge The ocean is an interconnected global ecosystem
More information1 November, 2013 or earlier
Job Description JOB TITLE REPORTING RELATIONSHIPS COMPANY START DATE Research Fellow/Senior Research Fellow Deputy Director, The George Institute India Programme Head, Global Surgery and Disability Research,
More information29 October For immediate release MEDIA RELEASE
29 October 2009 For immediate release MEDIA RELEASE EXPECTANT MOMS, BABIES SUBJECTS OF NEW STUDY TO FIND WAYS TO PREVENT OBESITY AND DIABETES - Official launch of Growing Up in Singapore Towards healthy
More informationWellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries.
IABC Wellington: Membership Marketing work plan 2015 Context Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries. IABC Wellington is a
More informationHARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur
HARM REDUCTION IN ASIA Adeeba Kamarulzaman University of Malaya, Kuala Lumpur Prevalence of HIV among IDUs: 2007 DU identified in 148 countries 15.9 million PWID No estimate of HIV prevalence 0%
More informationPromotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)
Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH) Presentation to ICDRA Members 16 September 2008 YEE Shen Kuan Division Director
More informationE-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY
E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY E-RARE THE ERA-NET FOR RESEARCH PROGRAMMES ON RARE DISEASES MAJOR FACTS ABOUT E-RARE ERA-NET
More informationHealth for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
More informationCollaboration with Cairo University. Cairo University, Faculty of Medicine
Collaboration with Cairo University Cairo University, Faculty of Medicine Kasr Al-Ainy Medical Faculty and Hospital established in 1827 1837, moved to 'Kasr Al-Aini' in Cairo until 1848, graduated 800
More information14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region
14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region Budiono Santoso Team Leader Essential Medicines & Technologies, World Health Organization,
More informationProf. Dr. Sehnaz Karadeniz
Prof. Dr. Sehnaz Karadeniz An ophthalmologist, Dr. Karadeniz has been actively involved in the field of diabetes for the past 20 years in a series of medical, scientific and social projects both at national
More information1 of 9 6/25/17 1:22 AM
News & Perspective Drugs & Diseases CME & Education Academy Consult Video Email This Your Name: Specialty: Emergency Medicine Allergy & Immunology Anesthesiology Business of Medicine Cardiology Critical
More informationPerspective from ASEAN: WHO support activities. Health and Communicable Disease Division, ASEAN Secretariat
Perspective from ASEAN: WHO support activities Health and Communicable Disease Division, ASEAN Secretariat The ASEAN CHARTER Signed at the 13 th ASEAN Summit on 20 November 2007 in Singapore It has been
More informationInformation contained in this listing is collected and maintained by the American Board of Internal Medicine.
1936-1940 1936 1937 1938 1939 1940 Decade Internal Medicine 27 209 90 227 255 808 1941-1950 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 Decade Internal Medicine 242 204 342 271 314 473 654 486 335
More informationSupplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016
Supplementary Data of Financial Statements for the third quarter ended December 31, 2016 January 31, 2017 NITTO DENKO CORPORATION CONTENTS Page Business 1 Segment Information 2 Segment Information By Geographic
More informationThere is no prevention. There is no cure.
LEADERS SUMMIT DAY 2, TUESDAY 17 APRIL 2018 GLOBAL ISSUES LOCAL RESPONSES Workshop 3 Leadership Dementia Care Skills Train-The-Trainer Programme in Malaysia and Brunei: An Asia Pacific Region Initiative
More informationRheumatoid Arthritis Learning Collaborative
Rheumatoid Arthritis Learning Collaborative Sponsored by AMGF and AbbVie August 12 14, 2015 USMD Rheumatoid Arthritis Collaborative Medical Group Profile USMD Health System: May 7, 2010 Medical Clinic
More informationCurriculum Overview for 1 st year students of English Division of the Medical Faculty Medical University of Gdańsk Academic Year 2016/2017
Curriculum Overview for 1 st year students of English Division of the Medical Faculty Gross Anatomy with Neuroscience 18 208 58-150 Exam Histology with Cell Physiology 9 102 24-78 Exam Biophysics 5 60
More informationstrategic plan strong teeth strong body strong mind Developed in partnership with Rotary Clubs of Perth and Heirisson
strategic plan 2012-2016 strong teeth strong body strong mind CONTENTS Introduction 2 Key Result Area 1 Dental Health Education 5 Key Result Area 2 Dental Treatment 7 Key Result Area 3 Advocacy 9 Key
More informationHEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018
HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:
More informationStrong Political Commitment and Speed of Action - Key to Success in SARS Containment in Vietnam
Strong Political Commitment and Speed of Action - Key to Success in SARS Containment in Vietnam A presentation by Prof. Nguyen Van Thuong Vice Minister of Health of Vietnam at the WHO Global Conference
More informationJOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014
JOINT STATEMENT OF ASEAN PLUS THREE HEALTH MINISTERS SPECIAL MEETING ON EBOLA PREPAREDNESS AND RESPONSE Bangkok, Thailand, 15 December 2014 We, the Health Ministers of Brunei Darussalam, Cambodia, Indonesia,
More informationEssential Medicines. WHO
12 Health Technology and Pharmaceuticals Participants to the Workshop on Pharmaceutical Policies and Access to Good Quality Essential Medicines for Pacific Island Countries observing pharmaceutical services
More informationREGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?
REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN? Rosanna Tarricone, PhD Associate Dean, Government Health and Non Profit Division Issue Panel Opportunities and challenges in international
More informationUT Health Physicians. Carlos A. Rosende, M.D., F.A.C.S. Executive Vice Dean for Clinical Affairs Executive Director, UT Health Physicians
UT Health Physicians Carlos A. Rosende, M.D., F.A.C.S. Executive Vice Dean for Clinical Affairs Executive Director, UT Health Physicians UT Medicine UT Health Physicians Our New Name UT Health San Antonio
More informationEnc 9 Appendix 5 RTT Recovery Plan June 2015 PROGRESS UPDATE MANAGE R LEAD RISKS TO DELIVERY OF ACTION COMPLETION ON DATE NUMBER ACTION EXEC LEAD
Enc 9 Appendix 5 RTT Recovery Plan June 2015 Status Key 5 Complete 4 On track 3 Some delay-expect to complete as planned or implemented but not consistently delivering 2 Significant delay unlikely to be
More information2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation
2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,
More informationSetting the scene Background of the Radiation Protection Culture initiative
IRPA IOMP WHO Workshop Radiation Protection Culture in Medicine Geneva, 30.11. 02.11.2015 Setting the scene Background of the Radiation Protection Culture initiative Bernard Le Guen, IRPA Executive Officer
More informationPolicy of Conflict of Interest in Clinical Research
Policy of Conflict of Interest in Clinical Research The Japan Society of Hepatology Academic-industrial collaboration has been assigned as a national strategy to assist in establishing Japan as a nation
More informationSOLUTION MATCH Ospedale Pediatrico Bambin Gesù is looking for a remote monitoring and symptom reporting solution to detect problems with shunts in
SOLUTION MATCH Ospedale Pediatrico Bambin Gesù is looking for a remote monitoring and symptom reporting solution to detect problems with shunts in paediatrics ABOUT Ospedale Pediatrico Bambin Gesù Bambino
More informationWho we are. We envision a world where high quality eye health and vision care is accessible to all people.
Who we are The World Council of Optometry (WCO) is an international optometric association founded in 1927. The WCO represents over 200,000 optometrists in more than 60 countries, through almost 300 Country,
More informationThe Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration
The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration 2012.10.23 (TUE) North-East Asia Forum on Trade and Transport Facilitation 1 CONTENTS 1. Significance of Trilateral
More informationDevelopment Bank of Southern Africa Amendment Bill [B ]
Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Standing Committee on Finance National Assembly 8 July 2014 Presenters: Mr Lefentse Radikeledi Director: Asset and Liability Management
More informationLetter to the AMGA Board of Directors... 1 Introduction... 3
Table of Contents Letter to the AMGA Board of Directors... 1 Introduction... 3 Section I: Executive Summary Survey at a Glance... 6 Participant Profile... 10 Survey Methodology... 19 How to Use This Report...
More informationInitiatives of ASEAN in Promoting an Active Ageing Society. Edgar Gonzales Pato ASEAN Secretariat Tokyo, Japan December 3-5,2013
Initiatives of ASEAN in Promoting an Active Ageing Society Edgar Gonzales Pato ASEAN Secretariat Tokyo, Japan December 3-5,2013 What the Numbers Are Saying In ASEAN for year 2010, we have countries which
More informationANNEX: Trilateral Meetings since November 2015
ANNEX: Trilateral Meetings since November 2015 PART I: Trilateral Ministerial Meetings 8 th Tripartite Health Ministers' Meeting (November 29, 2015, Japan) 7 th Trilateral Culture Ministers Meeting (December
More informationLetter to the AMGA Board of Directors...1 Introduction...3
Table of Contents Letter to the AMGA Board of Directors...1 Introduction...3 Section I: Executive Summary Survey at a Glance...6 Participant Profile...10 Survey Methodology...18 How to Use This Report...21
More informationThe value of integrated reporting
The value of integrated reporting Jesper Lindhardt Director Triple Bottom Line Strategy & Performance Management Novo Nordisk at a glance Key facts A focused pharmaceutical company with leading positions
More informationThe CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010
The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010 Dr C Bolton Moore Deputy Medical Director CIDRZ Ministry of Health Zambia University of
More informationHOSPITAL In The HOME SOCIETY AUSTRALASIA STATEGIC PLAN
HOSPITAL In The HOME SOCIETY AUSTRALASIA STATEGIC PLAN 2015-2018 Mission; The Hospital in the Home (HITH) Society of Australasia is the peak independent industry organisation developed by leaders in their
More information6 Opportunities for Improving Pathways to Market: A Global Perspective on Dementia
6 Opportunities for Improving Pathways to Market: A Global Perspective on Dementia Raj Long Senior Regulatory Officer Bill & Melinda Gates Foundation Director Dementia Integrated Development UK HMG World
More informationUse and Perception of Scientific Medical Reprints
TITLE OF PRESENTATION Use and Perception of Scientific Medical Reprints Elsevier Health Panel Research Report Date August 2017 I 2 Report Structure Research Objectives, Methodology & Sample Executive Summary
More informationEthics Considaration in Health Databases and Biobank
Ethics Considaration in Health Databases and Biobank Associate Professor Dr Chee Piau WONG MBBS, MRCP, FRCPCH, PhD, CCST, AMM Jeffrey Cheah School of Medicine and Health Sciences Presentation Malaysia
More informationFMD Control in South East Asia: science based approach to development of roadmaps and PVS Tools to support capacity building.
FMD Control in South East Asia: science based approach to development of roadmaps and PVS Tools to support capacity building Ronello Abila Sub-Regional Representative for SE Asia OUTLINE SEACFMD Campaign
More informationThe Development of Rehabilitation Services in the Australasian Region
The Development of Rehabilitation Services in the Australasian Region John OLVER AM MBBS MD FAFRM (RACP) Director Rehabilitation Epworth Healthcare Professor Rehabilitation Medicine Department of Medicine
More informationBig Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit
Big Data & Predictive Analytics Case Studies: Applying data science to human data 1.03.2018 Big-Data.AI Summit Dr. Arnim Jost, Commercial Director Technology Copyright 2017 IQVIA. All rights reserved.
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationKenya Association of Dermatologists. Biennial Conference Abadare Country Club, Nyeri. 4/29/2016.
Kenya Association of Dermatologists Biennial Conference 2016. Abadare Country Club, Nyeri. 4/29/2016. Prof. T.M.Munyao. Department of Clinical Medicine And Therapeutics. School Of Medicine. College Of
More informationHuman Papillomavirus Vaccination Programme in Malaysia
2016/SOM3/HWG-LSIF/WKSP/010 Session Human Papillomavirus Vaccination Programme in Malaysia Submitted by: Malaysia Accelerating Action on Human Papillomavirus and Cervical Cancer Prevention and Control
More informationHIV / AIDS & HUMAN RIGHTS
SIXTH ANNUAL MEETING Asia Pacific Forum of National Human Rights Institutions "A Partnership For Human Rights In Our Region" HIV / AIDS & HUMAN RIGHTS 24 th 27 th September 2001 Colombo, Sri Lanka 1 BACKGROUND
More informationAsia s Diabetes Challenge
Asia s Diabetes Challenge 12 th Geneva Association Health and Aging Conference Karl-Heinz Jung Head, Japan, MENA & International 1. Facts about Diabetes 2. Asia Feeling the Heat 3. Case for Private Insurance
More informationThe Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative
The Value of Product Development Partnerships in Vaccine Innovation Hansi J. Dean International AIDS Vaccine Initiative The Product Development Partnership Model A non-profit partnership of public and
More informationPOLICY ANALYST JOB DESCRIPTION
POLICY ANALYST JOB DESCRIPTION August 2010 Location: Hours of Work: Responsible to: National Office, Auckland 30 hours per week Executive Director The NZAF has an expectation that all staff will: Demonstrate
More information